Imaging in Rheumatologic Disease

Introduction

Imaging detects joint inflammation erosions and soft tissue changes in rheumatologic diseases and guides diagnosis and treatment monitoring. Modalities include radiography ultrasound MRI and nuclear medicine depending on disease and clinical question. Early imaging supports prompt therapy to prevent irreversible damage.

Ultrasound and MRI

Musculoskeletal ultrasound detects synovitis tenosynovitis and guides joint injections while MRI visualizes bone marrow edema and early erosive changes. Whole body MRI can assess multifocal disease activity in systemic conditions. Quantitative imaging supports objective monitoring of therapeutic response.

Radiography and Nuclear Medicine

Radiographs document chronic structural damage and joint space narrowing and remain important for long term assessment. Bone scintigraphy and PET can detect occult inflammatory activity and systemic involvement in selected cases. Imaging complements clinical and serologic assessment for comprehensive care.

Multidisciplinary Management

Imaging findings are integrated with rheumatology clinical assessment and laboratory markers to guide immunomodulatory therapy and monitor adverse effects. Standardized scoring systems and imaging protocols improve comparability in trials and practice. Collaboration supports personalized treatment strategies.

New Radiology Articles

Imaging in Rheumatologic Disease